GLP-1 Meds and Breastfeeding Study
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a type of diabetes/weight loss medication (GLP-1 RA, given as a shot) affects milk production in breastfeeding mothers. It may help women who need this medicine while nursing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a breastfeeding mother of one or more babies.
- You pump or nurse at least 4 times a day.
- You are eligible to receive a GLP-1 RA as a shot (not a pill).
- You have access to a breast pump if needed.
- You are willing to give 1–3 ounces of breastmilk at each study visit.
- You are willing to weigh yourself daily and keep breastfeeding for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
This trial tests if a GLP-1 receptor agonist can help people with multiple sclerosis who have a high BMI. It may reduce inflammation and improve health.
This study tests whether switching to an oral weight-loss medication can help you keep off the weight you lost after stopping a GLP-1 injection like semaglutide or tirzepatide. You might qualify if you live in Massachusetts, are between 18 and 80, have a BMI of 30 or higher, lost at least 10% of your body weight on these injections, and are willing to be randomly assigned to a new treatment.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
This trial tests a weight-loss medication (GLP-1 receptor agonist) combined with dietary protein to see if it helps protect muscle while losing fat. It is for adults with obesity who are not taking certain other medications or supplements.
This trial tests whether a special GLP-1 formula can help regulate blood sugar and increase GLP-1 levels in people with higher body fat. It may offer a new way to support metabolic health.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.